(Q34874473)

5 August 2017

0 references

Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis (English)

1 reference

5 August 2017

0 references

1 reference

1 reference

M A D Vente

1

1 reference

5 August 2017

M Wondergem

2

1 reference

5 August 2017

I van der Tweel

3

1 reference

5 August 2017

M A A J van den Bosch

4

1 reference

5 August 2017

B A Zonnenberg

5

1 reference

5 August 2017

M G E H Lam

6

1 reference

5 August 2017

A D van Het Schip

7

1 reference

5 August 2017

J F W Nijsen

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

7 November 2008

1 reference

5 August 2017

1 reference

5 August 2017

volume

19

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

951-959

1 reference

https://scigraph.springernature.com/pub.10.1007/s00330-008-1211-7

5 August 2017

exact match

0 references

cites work

Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic im

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Radiological diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1211-7

A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy

21 January 2018

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Glass yttrium-90 microspheres for patients with colorectal liver metastases

1 reference

12 December 2020

Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization.

1 reference

12 December 2020

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications

1 reference

12 December 2020

Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.

1 reference

12 December 2020

Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.

1 reference

12 December 2020

Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.

1 reference

12 December 2020

Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio

1 reference

12 December 2020

Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors

1 reference

12 December 2020

Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.

1 reference

12 December 2020

Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma

1 reference

12 December 2020

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

1 reference

12 December 2020

Hepatocellular carcinoma: current management and future trends.

1 reference

12 December 2020

The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors

1 reference

12 December 2020

Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

1 reference

12 December 2020

Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors

1 reference

12 December 2020

Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres.

1 reference

12 December 2020

Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study

1 reference

12 December 2020

Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases

1 reference

12 December 2020

Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.

1 reference

12 December 2020

Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo.

1 reference

12 December 2020

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients

1 reference

12 December 2020

A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.

1 reference

12 December 2020

Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres

1 reference

12 December 2020

Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation

1 reference

12 December 2020

The binomial distribution of meta-analysis was preferred to model within-study variability.

1 reference

12 December 2020

Radionuclide liver cancer therapies: from concept to current clinical status

1 reference

12 December 2020

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology

1 reference

12 December 2020

Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.

1 reference

12 December 2020

Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization

1 reference

12 December 2020

Technical aspects of radioembolization with 90Y microspheres.

1 reference

12 December 2020

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

1 reference

12 December 2020

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

1 reference

12 December 2020

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

1 reference

12 December 2020

Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients

1 reference

12 December 2020

90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.

1 reference

12 December 2020

Regression of liver metastases following treatment with yttrium-90 microspheres

1 reference

12 December 2020

Gastroduodenal injury after radioembolization of hepatic tumors.

1 reference

12 December 2020

Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases

1 reference

12 December 2020

90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival

1 reference

12 December 2020

Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up

1 reference

12 December 2020

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

1 reference

12 December 2020

Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres

1 reference

12 December 2020

Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs.

1 reference

12 December 2020

10.1007/S00330-008-1211-7

Identifiers

DOI

1 reference

5 August 2017

1 reference